These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38959733)

  • 1. Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis.
    Xu C; Wei Z; Lv L; Dong X; Xia W; Xing J; Liu H; Zhao X; Liu Y; Wang W; Jiang H; Gong Y; Liu C; Xu K; Wang S; Akimoto Y; Hu Z
    Biochem Biophys Res Commun; 2024 Oct; 727():150317. PubMed ID: 38959733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
    Yang T; Chen W; Gan K; Wang C; Xie X; Su Y; Lian H; Xu J; Zhao J; Liu Q
    J Transl Med; 2023 Nov; 21(1):839. PubMed ID: 37993937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling.
    Lu J; Shi X; Fu Q; Han Y; Zhu L; Zhou Z; Li Y; Lu N
    Cell Mol Biol Lett; 2024 Jul; 29(1):100. PubMed ID: 38977961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3.
    Zhang Y; Zhang S; Wang Y; Yang Z; Chen Z; Wen N; Yang M; Huang Z; Xie Y; Cai L
    Oxid Med Cell Longev; 2021; 2021():2896674. PubMed ID: 34820053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid zinc finger 1 knockdown promotes osteoclastogenesis and bone loss in part by regulating RANKL-induced ferroptosis of osteoclasts through Nrf2/GPX4 signaling pathway.
    Qu Z; Zhang B; Kong L; Zhang Y; Zhao Y; Gong Y; Gao X; Feng M; Zhang J; Yan L
    J Leukoc Biol; 2024 Apr; 115(5):946-957. PubMed ID: 38266238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDK2 Deficiency Prevents Ovariectomy-Induced Bone Loss in Mice by Regulating the RANKL-NFATc1 Pathway During Osteoclastogenesis.
    Lee JM; Kim MJ; Lee SJ; Kim BG; Choi JY; Lee SM; Ham HJ; Koh JM; Jeon JH; Lee IK
    J Bone Miner Res; 2021 Mar; 36(3):553-566. PubMed ID: 33125772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPKα1 negatively regulates osteoclastogenesis and mitigates pathological bone loss.
    Ribeiro MSP; Venturini LGR; Speck-Hernandez CA; Alabarse PVG; Xavier T; Taira TM; Duffles LF; Cunha FQ; Fukada SY
    J Biol Chem; 2023 Dec; 299(12):105379. PubMed ID: 37871745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A p38 MAP kinase inhibitor suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss through the inhibition of bone turnover.
    Xu C; Wei Z; Dong X; Xing J; Meng X; Qiu Y; Zhou H; Zheng W; Xu Z; Huang S; Xia W; Lv L; Jiang H; Wang W; Zhao X; Liu Z; Akimoto Y; Zhao B; Wang S; Hu Z
    Biochem Pharmacol; 2024 Aug; 226():116391. PubMed ID: 38914317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPSTI1 promotes osteoclast differentiation and bone resorption by PKR/NF-κB signaling.
    Zhang M; Yang E; Qin X; Zhang S; Zhu Y; Fu H; He B
    Biochem Biophys Res Commun; 2024 Nov; 734():150463. PubMed ID: 39083969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W; Zhu G; Tang J; Zhou HD; Li YP
    J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption.
    Li S; Teguh D; Wu D; Liu L; Hu C; Yuan J; Inderjeeth CA; Xu J
    J Cell Physiol; 2023 Aug; 238(8):1823-1835. PubMed ID: 37334837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
    Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
    Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperlongumine, a
    Luo N; Zhang L; Xiu C; Luo X; Hu S; Ji K; Liu Q; Chen J
    Food Funct; 2024 Feb; 15(4):2154-2169. PubMed ID: 38311970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.